ClinicalTrials.gg
Active, not recruitingNCT02934451Updated Jan 27, 2026

Dental Malocclusion and Craniofacial Development in OI

An observational study in Osteogenesis Imperfecta, sponsored by Baylor College of Medicine. Active, not recruiting at 3 sites in 2 countries. Open to participants aged 10 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by Baylor College of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
75
Ages
10 Years to 100 Years
Sex
All
01

Study summary

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss and pain and difficulty getting around. People with moderate to severe OI may also be diagnosed with dentinogenesis imperfecta (DI). DI is characterized by grey or brown teeth that may chip and wear down and break easily. People with DI may also have skull and neck defects. These patients may have severe teeth misalignment resulting in clinically significant chewing problems. Teeth misalignment in OI is very hard to treat because of the quality and quantity of bone. The overall goal of this study is to improve dental health to improve the quality of life of people with OI.

Read the detailed description

Investigators will look at dental health in people with OI and will describe teeth misalignment and head and neck defects in individuals with moderate to severe Osteogenesis Imperfecta (OI).

Investigators will look at results from the Longitudinal study of OI to complete the study evaluations. Several x-rays will be performed for this study. Participants will have a 3D scan of the mouth and a Cone Beam CT scan of the jaw at a baseline visit and at 3 years after the baseline visit. These study visits can be at the same time as the Longitudinal Study of OI study visits.

02

Conditions studied

  • Osteogenesis Imperfecta
03

In context

Osteogenesis Imperfecta

84 studies on the registry are indexed under Osteogenesis Imperfecta; 20 are open to participants now.

This study's enrollment of 75 is close to the median of 75 across 23 observational studies indexed under Osteogenesis Imperfecta.

Browse Osteogenesis Imperfecta studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 747 studies on the registry; 110 are open to participants now.

Of its 84 completed or terminated interventional studies of FDA-regulated products, 45 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Individuals with Severe OI

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males and females with Clinical diagnosis of OI other than OI type I
  • Individuals 10 years or older
  • Participant of the Brittle Bone Disease (BBD) Longitudinal Study (7701)

Exclusion criteria

Exclusion Criteria:

  • Individuals who cannot be correctly positioned for valid radiographic analysis (e.g., due to severe scoliosis or short neck secondary to basilar invagination)
  • Women who are pregnant
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
75 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Teeth Misalignment

    Measure teeth misalignment in individuals with moderate to severe OI using scans of the teeth.

    Time frame: 5 years

Secondary outcomes

  1. Neck Defects

    Determine neck defects in individuals with moderate to severe OI using scans of the neck and jaw.

    Time frame: 5 years

07

Study locations

3 sites
08

References and documents

Individual participant data

Plan to share: No — The clinical information collected for this study will be stored in a computer database at the Data Management and Coordinating Center at the University of South Florida in Tampa, FL and also sent to a Federal data repository. A data repository provides a way for researchers to store the information collected during the research study for future research studies. The data management center uses several layers of protection for the clinical data stored in its computer database. It meets all of the local and federal security requirements for research datacenters. Information is stored only using a study identification number. Only the investigators and the study staff who collect and enter study data will have access to the key which links the identification number to the participant.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2016 (actual). Primary completion is estimated for Dec 2027, 136 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 12, 2016
First posted
Oct 17, 2016
StartActual
Aug 2016
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Jan 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02934451
Responsible party
Brendan Lee (Professor and Chairman, Baylor College of Medicine) — Principal investigator
First posted
Oct 17, 2016
Start date
Aug 2016
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jan 27, 2026

Study contacts

Jean-Marc Retrouvey, D.M.D.
study chair · McGill University
Reid Sutton, M.D.
study chair · Baylor College of Medicine
Frank Rauch, M.D.
study chair · Shriners Hospital for Children

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion